CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose is to compare median two-year clinical outcome after OCT guided vs. standard guided revascularization of patients requiring complex bifur...
Warsaw, Poland and 37 other locations
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Ph...
Warsaw, Poland and 83 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Warsaw, Poland and 171 other locations
of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart...
Phase 2
Warszawa, Poland and 139 other locations
TripleTRE investigates the effect of initial triple combination therapy (oral endothelin receptor antagonist (ERA) + oral phosphodiesterase tyüe-5 in...
Phase 4
Otwock, Poland and 18 other locations
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...
Phase 3
Warsaw, Poland and 826 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Warsaw, Masovian Province, Poland and 583 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Warsaw, Poland and 742 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Warsaw, Masovian Voivodeship, Poland and 672 other locations
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. ...
Phase 3
Warsaw, Poland and 807 other locations
Clinical trials
Research sites
Resources
Legal